Published in AIDS Weekly, October 27th, 2003
The AlphaVax grants total $16.6 million and were made by the National Institute of Allergy and Infectious Disease (NIAID), part of the NIH in Bethesda, Maryland, an agency of the U.S. Department of Health and Human Services.
The first grant for $9.1 million is to develop a vaccine against botulinum neurotoxins, and the second $7.5 million grant is for a vaccine against a group of equine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.